AGE FEATURES OF INTESTINAL AMOEBIASIS
https://doi.org/10.21508/1027-4065-2018-63-4-73-78
Abstract
Study objective. To establish clinical and epidemiological features of intestinal amebiasis in adults and children at the present stage. A retrospective analysis of patient histories of 90 cases of intestinal amebiasisin patients aged 3 to 40 years who were on inpatient treatment in Regional Infectious Clinical Hospital named after A.M Nichogi, Astrakhan, in the period from 2014 to 2017. The diagnosis of amebiasis was confirmed by microscopy of feces, detection of antibodies by using reaction of indirect hemagglutination (RHAG) with a specific antigen, determination of DNA of the parasite by polymerase chain reaction (PCR).
Results. It was determined that the incidence of intestinal amebiasis in the Astrakhan region is sporadic with the involvement in the epidemic process of persons of working age from 18 to 40 years (75.6%) and children aged 3 to 10 years (24.6%) of organized groups living in the city. Acute intestinal amebiasis in 86.8% of adults proceeded in mild to moderate form. The clinical course of the disease was characterized by a gradual onset in 82.4%, mucosal-bloody stool in 94.1%, the outcome of a chronic recurrent form in 11.8%. Raspberry jelly-like stool, extraintestinal complications of amebiasis, characteristic of amebiasis of previous years, were absent.
The features of intestinal amebiasis in children were: acute onset of the disease in 63.6%, fever 38°C and above in 54.5%, abdominal pain in 95.5%, prolonged diarrhoea with a stool frequency of more than 10 times in 72.7%, stool with blood mucus in 95.5%, tenesmus in 36.4%, dehydration in 18.6% of patients. The mild form of the disease in children was not observed, severe was observed in 54.5%, moderate in 45.5%. The combined course of intestinal amebiasis with bacterial dysentery, proceeded more severely, changed clinical symptoms of the disease, made it difficult to diagnose amebiasis in a timely manner.
About the Authors
G. A. Kharchenko
Astrakhan State Medical University of the Ministry of Health of the Russian Federation
Russian Federation
Astrakhan
Russian Federation
Astrakhan
O. G. Kimirilova
Astrakhan State Medical University of the Ministry of Health of the Russian Federation
Russian Federation
Astrakhan
Russian Federation
Astrakhan
References
1. Onishchenko G.G. Оn measures to strengthen the prevention of parasitic diseases in Russia.Med parazitol 2003; 3: 3–7. (in Russ)
2. Ciftci A.O. Karnak I., Sencak M.E., Kale G, Buyukpamukcu N. Spectrum of complicated intestinal amebiasis throughresected specimens incidence and outcome. J Pediatr Surg 1999; 34: 1369–1373.
3. Evangelopoulos A., SpanakosG., PatsoulaE., Vakalis N.,Legakis N. Anested, multiplex, PCR assay forthe simultaneous detection and differentiation of Entamoeba histolytica and Entamoeba dispar in faeces. Ann Trop Med Parasitol 2000; 94: 233–240.
4. Lowther S.A., Dworkin M.S., Hanson D.L. Entamoeba histolytica /Entamoeba dispar infections in human immunodeficiency virus-infected patients in the United States. Clin Infect 2000; 30: 955–959.
5. Lebbad M., Svärd S.G. PCR differentiation of Entamoeba histolytica and Entamoeba dispar from patients with amoeba infection initially diagnosed by microscopy. Scand J Infec Diseases 2005;37(9): 680–685.
6. Lysenko A.Yа., Vladimova M.G., Kondrashin A.V. Clinical Parasitology. Geneva: Izdatel’stvo VOZ, 2002; 734. (in Russ)
7. Sergeev V.P. Parasitic diseases of today and tomorrow. Qualityoflife. Meditsina, 2004; 1: 10–15. (in Russ)
8. Espinosa-Cantellano M., Martinez-Palomo A. Pathogenesis of intestinal amebiasis: from molecules to disease. Clin Microbiol Rev 2000; 13: 318–331.
9. Que X., Reed S.L. Cysteine proteinases and the pathogenesis of amoebiasis. Clin Microbiol Rev 2000; 13: 196–206.
10. Acuna-Soto R., Maguire J.H., Wirth D.F. Gender distribution in asymptomatic and invasive amebiasis. Am J Gastroenterol 2000; 95: 1277–1283.
11. Shiruma T.M., Obata H., Karasawa E., Hayashi N., Yamaura H. A recurrent case of amebic liver abscess seventeen years after the firs occurence. Kansenshogaku Zasshi 2000; 74: 585–588.
12. Yushchuk N.D., Vengerov Yu.Ya. Lectures on infectious diseases. 3rd ed. Moscow: Izdatel’stvo Meditsina 2007; 1032. (in Russ)
13. Astaf’eva N.V., Bykova R.N., Tokmalaev A.K., Korovushkin V.G., Kuznecov Eh.F., Mihalevskaya L.A. et al. Intestinal and extraintestinal amoebiasis: clinical observations. Medicinskaya parazitologiya i parazitarnye bolezni 2005; 2: 18–21. (in Russ)
14. Alikeeva G.K., Kuhtevich E.V., Yushchuk N.D., Sajfullina N.H. Amoebiasis. Lechashchij vrach 2011; 10: 43–46. (in Russ)
15. Hung C.C., Chen P.J., Hsieh S.M., Wong J.M., Fang C.T., Chang S.C. et al. Invasive amoebiasis: an emerging parasitic disease in patients infected with HIV in an area endemic for amoebic infection. AIDS 1999; 13: 2421–2428.
16. Shamsuzzama S.M., Hague R., Hasin S.K. Socioeconomic status, clinical features, laboratory and parasitological findings of hepatic amebiasis patients – a hospital based prospective study in Bangladesh. Southeast Asian J Trop Med Public Health 2000; 31: 399–404.
17. Shiruma T.M., Obata H., Karasawa E., Hayashi N., Yamaura H. A recurrent case of amebic liver abscess seventeen years after the firs occurence. Kansenshogaku Zasshi 2000; 74: 585–8.
18. Badalamenti S., Jameson J.E., Reddy K.R. Amebiasis. Curr Trea Options Gastroenterol 1999; 2: 97–103.
19. Bronshtejn A.M., Malyshev N.A., Luchshev V.I. Amebiasis: clinical features, diagnosis, treatment. Klinicheskaya mikrobiologiya i antimikrobnaya himioterapiya 2001; 3(3): 215–222. (in Russ)
20. Abbas M.A., Mulligan D.C., Ramzan N.N., Blair J.E., Smilack J.D., Shapiro M.S. et al. Colonic perforation in unsuspected amebic colitis. Dig Dis Sci 2000; 45: 1836–1841.
21. Hanna R.M., Dahniya M.H., Badr S.S., El-Batagy A. Percutaneus catheter drainage in drug-resistant amoebic liver abscess. Trop Med Int Health 2000; 5: 578–581.
22. Huston C.D., Petri W.A. Amebiasis: clinical implications of the recognition of Entamoebadispar. Curr Infect Dis Rep 1999; 1: 441–447.
23. Lysenko A.Ya., Gorbunova Yu.P., Avdyuhina T.I., Konstantinova T.I. Laboratory diagnostics of intestinal protozoa. Tutorial M: Izdatel’stvo TSOLIUV 2007; 43. (in Russ)
24. Vitkovskaya V.A. Clinic and treatment of intestinal amoebiasis. Uspekhi sovremennogo estestvoznaniya 2003; 9: 84–85. (in Russ)
25. Salles J.M., Bechara C., Tavares A.M. Comparative study of the efficacy and tolerability of secnidazole suspension (single dose) and tinidazole suspension (two days dosage) in the treatment of amebiasis in children. Braz J Infect Dis 1999; 3: 80–88.
26. Yushchuk N.D., Vengerov Yu.Ya., Kryazheva S.S. Infectious diseases of man. Moscow: Izdatel’stvo Meditsina 2009; 20– 22. (in Russ)
Review
For citations:
Kharchenko G.A., Kimirilova O.G. AGE FEATURES OF INTESTINAL AMOEBIASIS. Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics). 2018;63(4):73-78. (In Russ.) https://doi.org/10.21508/1027-4065-2018-63-4-73-78
Views:
1185
Email this article 